dsm-firmenich Company Research Report

Company Overview

Name: dsm-firmenich

Mission: To bring progress to life by being a leading co-creation and innovation partner in nutrition, health, and beauty, addressing what is essential for life, desirable for society, and sustainable for the planet.

Founded by: The data does not specify founders; however, dsm-firmenich is the result of a merger between DSM and Firmenich as of May 9, 2023.

Key People: The executive team is led by CEO Dimitri de Vreeze and Chairman of the Board Thomas Leysen.

Headquarters: The company is jointly headquartered in Kaiseraugst, Switzerland, and Maastricht, Netherlands.

Number of Employees: Approximately 30,000 globally.

Revenue: Over €12 billion.

Known for: Innovating in the fields of nutrition, health, and beauty, with a legacy of 150+ years of scientific discovery and innovation.

Products

Business Areas

1. Perfumery & Beauty: Specializes in creating superior scents with sustainable ingredients.
2. Taste, Texture & Health: Collaborates with the food and beverage industry to balance taste and sustainability.
3. Health, Nutrition & Care: Offers essential nutrients for health across various life stages.
4. Animal Nutrition & Health: Focuses on sustainable animal protein production and transforming global food systems.

Product Features:

Synbiotic Solutions: A partnership with Lallemand Health Solutions to create synergistic synbiotic products for infant nutrition, combining HMOs and probiotics to mimic the benefits of breast milk.

Vitamin Transformation Program: A restructuring initiative aimed at cost reduction and profitability in vitamins, making a significant contribution to adjusted EBITDA.

Feed Additives: Solutions like feed additives to reduce methane emissions and support sustainable farming.

Recent Developments

Financial Performance: In H1 2024, the company reported sales of €6,298 million, a 41% increase on an IFRS basis from the previous year.

Strategic Actions:

Completed the sale of the yeast extract business to Lesaffre and the MEG-3® fish oil business to KD Pharma Group SA, as part of portfolio optimization.

Announced the separation of the Animal Nutrition & Health business.

New Initiatives:

Launched a new company website to enhance user experience.

Introduced a €1.8 billion revolving credit facility to streamline its financing structure.

Synergies & Transformations: Achieved €95 million in synergies and transformation benefits in the first half of 2024 from integration and restructuring efforts.

Sustainability Efforts: Commitment to reducing environmental impact through innovative solutions and sustainable practices.

Conclusion

dsm-firmenich stands as a global leader combining heritage and innovation in nutrition, health, and beauty. Through strategic mergers, a diversified workforce, and a strong commitment to sustainability and innovation, the company positions itself at the forefront of addressing critical global challenges. By leveraging its strengths and refining its portfolio, dsm-firmenich continues its mission to drive progress and improve lives worldwide.